Risk of Urinary Retention With Retigabine
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01462656 |
|
Recruitment Status :
Terminated
(This study was halted as the preliminary analysis revealed that the numbers were too low to warrant continuing the project)
First Posted : October 31, 2011
Last Update Posted : November 25, 2016
|
Sponsor:
GlaxoSmithKline
Information provided by (Responsible Party):
GlaxoSmithKline
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | August 2016 |
| Actual Study Completion Date : | August 2016 |